These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


477 related items for PubMed ID: 21348302

  • 21. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.
    Szliszka E, Helewski KJ, Mizgala E, Krol W.
    Int J Oncol; 2011 Oct; 39(4):771-9. PubMed ID: 21743964
    [Abstract] [Full Text] [Related]

  • 22. [Lidamycin induces apoptosis of human gastric carcinoma BGC823 cells and inhibits xenograft growth in nude mice].
    Zhang SH, Chen J, Jiang M, Zhen YS.
    Yao Xue Xue Bao; 2008 Jun; 43(6):601-4. PubMed ID: 18822962
    [Abstract] [Full Text] [Related]

  • 23. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J, Ouyang ZG, Zhang SH, Zhen YS.
    Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
    [Abstract] [Full Text] [Related]

  • 24. Cytotoxic effects of camptothecin and cisplatin combined with tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in a model of primary culture of non-small cell lung cancer.
    Frese S, Schüller A, Frese-Schaper M, Gugger M, Schmid RA.
    Anticancer Res; 2009 Aug; 29(8):2905-11. PubMed ID: 19661294
    [Abstract] [Full Text] [Related]

  • 25. The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.
    Azijli K, van Roosmalen IA, Smit J, Pillai S, Fukushima M, de Jong S, Peters GJ, Bijnsdorp IV, Kruyt FA.
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1273-83. PubMed ID: 24744163
    [Abstract] [Full Text] [Related]

  • 26. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
    Ozören N, El-Deiry WS.
    Neoplasia; 2002 Jun; 4(6):551-7. PubMed ID: 12407450
    [Abstract] [Full Text] [Related]

  • 27. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA.
    Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726
    [Abstract] [Full Text] [Related]

  • 28. Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.
    Spierings DC, de Vries EG, Timens W, Groen HJ, Boezen HM, de Jong S.
    Clin Cancer Res; 2003 Aug 15; 9(9):3397-405. PubMed ID: 12960128
    [Abstract] [Full Text] [Related]

  • 29. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
    Azijli K, Yuvaraj S, van Roosmalen I, Flach K, Giovannetti E, Peters GJ, de Jong S, Kruyt FA.
    Apoptosis; 2013 Jul 15; 18(7):851-60. PubMed ID: 23456625
    [Abstract] [Full Text] [Related]

  • 30. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
    Zhu K, Fang W, Chen Y, Lin S, Chen X.
    Oncol Rep; 2014 Sep 15; 32(3):1234-42. PubMed ID: 25017445
    [Abstract] [Full Text] [Related]

  • 31. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
    Zhu HB, Huang XF, Hu JZ, Zhou W, Chen W, Chen LL, He C.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr 15; 30(4):245-9. PubMed ID: 18788624
    [Abstract] [Full Text] [Related]

  • 32. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
    Azijli K, Yuvaraj S, Peppelenbosch MP, Würdinger T, Dekker H, Joore J, van Dijk E, Quax WJ, Peters GJ, de Jong S, Kruyt FA.
    J Cell Sci; 2012 Oct 01; 125(Pt 19):4651-61. PubMed ID: 22797920
    [Abstract] [Full Text] [Related]

  • 33. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS.
    Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319
    [Abstract] [Full Text] [Related]

  • 34. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways.
    Lin FL, Hsu JL, Chou CH, Wu WJ, Chang CI, Liu HJ.
    Eur J Pharmacol; 2011 Jan 10; 650(1):120-9. PubMed ID: 20951126
    [Abstract] [Full Text] [Related]

  • 35. Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells.
    Zhen YZ, Lin YJ, Liu XJ, Shang BY, Zhen YS.
    Anticancer Drugs; 2013 Jul 10; 24(6):609-16. PubMed ID: 23698252
    [Abstract] [Full Text] [Related]

  • 36. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells.
    Ouyang W, Yang C, Zhang S, Liu Y, Yang B, Zhang J, Zhou F, Zhou Y, Xie C.
    Int J Oncol; 2013 Feb 10; 42(2):699-711. PubMed ID: 23258590
    [Abstract] [Full Text] [Related]

  • 37. N-Acetyl-Glucosamine Sensitizes Non-Small Cell Lung Cancer Cells to TRAIL-Induced Apoptosis by Activating Death Receptor 5.
    Liang Y, Xu W, Liu S, Chi J, Zhang J, Sui A, Wang L, Liang Z, Li D, Chen Y, Niu H.
    Cell Physiol Biochem; 2018 Feb 10; 45(5):2054-2070. PubMed ID: 29533936
    [Abstract] [Full Text] [Related]

  • 38. [Effect of lidamycin on mitochondria initiated apoptotic pathway in human cancer cells].
    Qiu Q, Wang Z, Jiang JM, Li DD.
    Yao Xue Xue Bao; 2007 Feb 10; 42(2):132-8. PubMed ID: 17518039
    [Abstract] [Full Text] [Related]

  • 39. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):543-52. PubMed ID: 18793956
    [Abstract] [Full Text] [Related]

  • 40. Chrysin promotes tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced apoptosis in human cancer cell lines.
    Li X, Wang JN, Huang JM, Xiong XK, Chen MF, Ong CN, Shen HM, Yang XF.
    Toxicol In Vitro; 2011 Apr 01; 25(3):630-5. PubMed ID: 21195158
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.